| Entry |
|
|---|
| Name |
Alovudine (USAN/INN) |
|---|
| Formula |
C10H13FN2O4
|
|---|
| Exact mass |
244.0859
|
|---|
| Mol weight |
244.2196
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
|
|---|
| Efficacy |
Antiviral, Reverse transcriptase inhibitor |
|---|
| Target |
HIV-1 reverse transcriptase [KO: K24802] |
|---|
| Pathway |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D02830 Alovudine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D02830 Alovudine (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C1y C 23.2400 -23.3100
2 O2x O 22.1200 -22.4700
3 C1x C 22.8200 -24.6400
4 C1y C 21.0000 -23.2400
5 C1y C 21.4200 -24.6400
6 C1b C 19.6700 -22.8200
7 O1a O 18.6200 -23.8000
8 X F 20.5800 -25.7600
9 N4y N 24.5730 -22.8820
10 C8y C 25.8009 -22.2230
11 N4x N 25.8467 -20.8238
12 C8y C 24.6577 -20.0845
13 C8y C 23.4203 -20.7460
14 C8x C 23.4445 -22.1453
15 O5x O 26.9959 -22.9650
16 O5x O 24.6332 -18.6914
17 C1a C 22.2246 -20.0430
BOND 18
1 2 4 1
2 3 5 1
3 4 6 1 #Up
4 6 7 1
5 4 5 1
6 1 2 1
7 1 3 1
8 5 8 1 #Down
9 1 9 1 #Up
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 2
15 9 14 1
16 10 15 2
17 12 16 2
18 13 17 1
|
|---|
